ERICA GIRARDEAU: Open Payments
NPI 1821757428 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 36 payments from 14 companies in 2025. Trend: 2023 $799 · 2024 $538 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $257 |
| Boston Scientific Corporation | 4 | $75 |
| Novo Nordisk Inc | 3 | $52 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 3 | $50 |
| ABBVIE INC. | 2 | $49 |
| PFIZER INC. | 2 | $43 |
| Ardelyx, Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: FARXIGA, WATCHMAN FLX, Cologuard Collection Kit, PREVNAR 20, Ozempic, MOUNJARO, IBSRELA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
